IHE Report / IHE Rapport / IHE - The Swedish Institute for Health Economics
Citation Profile [Updated: 2023-11-03 08:28:08]
5 Years H Index
1
Impact Factor (IF)
0.08
5 Years IF
0.08
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 2020 | 0 | 0.72 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.78 | |||||
| 2021 | 0 | 0.99 | 0 | 0 | 10 | 12 | 0 | 0 | 2 | 2 | 0 | 0 | 0.41 | |||||
| 2022 | 0.08 | 0.78 | 0.09 | 0.08 | 11 | 23 | 1 | 2 | 2 | 12 | 1 | 12 | 1 | 2 | 100 | 1 | 0.09 | 0.25 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2022 | Diagnosed but not treated: How to improve patient access to advanced NSCLC treatment in Europe. (2022). Wilking, Nils ; Lindgren, Peter ; Hofmarcher, Thomas. In: IHE Report / IHE Rapport. RePEc:hhs:ihewps:2022_002. Full description at Econpapers || Download paper | 2 |
| 2 | 2021 | Cancer care and access to cancer drugs in Asia-Pacific. (2021). Hofmarcher, Thomas ; Keel, George ; Lindgren, Peter. In: IHE Report / IHE Rapport. RePEc:hhs:ihewps:2021_003. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2022 | Diagnosed but not treated: How to improve patient access to advanced NSCLC treatment in Europe. (2022). Wilking, Nils ; Lindgren, Peter ; Hofmarcher, Thomas. In: IHE Report / IHE Rapport. RePEc:hhs:ihewps:2022_002. Full description at Econpapers || Download paper | 2 |
Citing documents used to
compute impact factor: 1
| Year | Title | |
|---|---|---|
| 2022 | Cancer Care in Türkiye in a European Context. (2022). Wilking, Nils ; Lindgren, Peter ; Hofmarcher, Thomas. In: IHE Report / IHE Rapport. RePEc:hhs:ihewps:2022_010. Full description at Econpapers || Download paper |
Recent citations
Recent citations received in 2022
| Year | Citing document | |
|---|---|---|
| 2022 | Cancer Care in Türkiye in a European Context. (2022). Wilking, Nils ; Lindgren, Peter ; Hofmarcher, Thomas. In: IHE Report / IHE Rapport. RePEc:hhs:ihewps:2022_010. Full description at Econpapers || Download paper |
10 most frequent citing series